Anti-calcitonin gene-related peptide monoclonal antibodies for the treatment of vestibular migraine: A prospective observational cohort study

Vestibular migraine is considered the most common cause of recurrent vertigo for which specific treatments are missing. Monoclonal antibodies against calcitonin gene-related peptide,, are effective in preventing migraine. Since CGRP is also detected in human cochlear and vestibular organs it may als...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Cephalalgia Ročník 43; číslo 4; s. 3331024231161809
Hlavní autoři:	Russo, Cinzia Valeria, Saccà, Francesco, Braca, Simone, Sansone, Mattia, Miele, Angelo, Stornaiuolo, Antonio, De Simone, Roberto
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England 01.04.2023
Témata:	Antibodies, Monoclonal - therapeutic use Calcitonin Gene-Related Peptide Cohort Studies Dizziness - drug therapy Headache - drug therapy Humans Migraine Disorders - prevention & control Prospective Studies Quality of Life Vertigo - chemically induced Vertigo - drug therapy anti-calcitonin gene-related peptide dizziness vestibular migraine monoclonal antibody vertigo Migraine
ISSN:	1468-2982, 1468-2982
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!